Korean J Physiol Pharmacol.
2000 Aug;4(4):283-289.
Effect of atrial natriuretic peptide on the proliferation and activity
of osteoblastic cells
- Affiliations
-
- 1Department of Dental Pharmacology, School of Dentistry, Dankook
University, San 7-1, Shinbu-dong, Cheonan, South Korea.
Abstract
- Natriuretic peptides comprise a family of three structurally related
peptides; atrial natriuretic peptide (ANP), brain natriuretic peptide
(BNP), and C-type natriuretic peptide (CNP). The present study was
performed to investigate the effect of ANP on the proliferation and
activity of ROS17/2.8 and HOS cells which are well-characterized
osteoblastic cell lines. ANP dose-dependently decreased the number of
ROS17/2.8 and HOS cells after 48-hour treatment. ANP generally
increased the alkaline phosphatase activity of ROS17/2.8 and HOS cells
after 48 hr treatment, regardless of the fact that basal activity of
alkaline phosphatase was much lower in HOS cells compared to that of
ROS17/1.8 cells. ANP increased the NBT reduction by ROS17/2.8 and HOS
cells. ANP showed the variable but no significant effect on the nitric
oxide production by ROS17/2.8 and HOS cells. ROS17/2.8 and HOS cells
produced and secreted gelatinase into culture medium, and this enzyme
was thought to be the gelatinase A type with the molecular weight
determination. The gelatinase activity produced by ROS17/2.8 cells was
increased by the treatment of ANP. However, the enzyme activity was not
affected by ANP treatment in the HOS cell culture. In summary, ANP
decreased the proliferation and increased the alkaline phosphatase
activity and NBT reduction of osteoblasts. These results indicate that
ANP is one of the important regulators of bone metabolism.